Non-ergot dopamine agonists and the risk of heart failure and other adverse cardiovascular reactions in Parkinson's disease

James A. G. Crispo; Yannick Fortin; Lindsey Sikora; Dafna Kohen; Lise M. Bjerre; Donald R. Mattison; Santiago Pérez-Lloret; Renée Hessian; Allison W. Willis; Daniel Krewski

doi:10.1002/14651858.cd011843

Non-ergot dopamine agonists and the risk of heart failure and other adverse cardiovascular reactions in Parkinson's disease

Identifier:nobleid.org/w1/20260515/0BC937FE

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/0BC937FE.svg?ark=w1%2F20260515%2F0BC937FE)](https://nobleid.org/work/w1/20260515/0BC937FE)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Santiago Pérez-Lloret

Renée Hessian

Allison W. Willis

Daniel Krewski

Claim authorship of this work

Non-ergot dopamine agonists and the risk of heart failure and other adverse cardiovascular reactions in Parkinson's disease

Identifier:nobleid.org/w1/20260515/0BC937FE

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/0BC937FE.svg?ark=w1%2F20260515%2F0BC937FE)](https://nobleid.org/work/w1/20260515/0BC937FE)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Santiago Pérez-Lloret

Renée Hessian

Allison W. Willis

Daniel Krewski

Claim authorship of this work